Organization type


  • Academic research institution
  • Contract research organization (CRO)

Early phases


  • Biomarker identification
  • Omics
    • Metabolomics
  • Target identification – new biological hypothesis
  • Target validation – Hypothesis verification

Screening


  • Assay development
    • In vitro screening models
    • In vivo screening models

Optimization phases


  • In vitro biochemical models(including assay/model development and testing)
  • In vivo animal models (including assay/model development and testing)
  • Mechanism of action (MoA) assessment
    • Omics profiling
    • Selectivity panels
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • ADME / DMPK

Terapeutic areas


  • Cancer
  • Cardiovascular
  • Metabolism / Endocrinology

Additional activities


  • Consulting services
  • Government initiatives supporting drug and research collaborations